Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases
- PMID: 27222762
- PMCID: PMC4756795
Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases
Abstract
The misuse of nootropics-any substance that may alter, improve, or augment cognitive performance, mainly through the stimulation or inhibition of certain neurotransmitters-may potentially be dangerous and deleterious to the human brain, and certain individuals with a history of mental or substance use disorders might be particularly vulnerable to their adverse effects. We describe four cases of probable nootropic-induced psychiatric adverse effects to illustrate this theory. To the best of our knowledge this has not been previously reported in the formal medical literature. We briefly describe the most common classes of nootropics, including their postulated or proven methods of actions, their desired effects, and their adverse side effects, and provide a brief discussion of the cases. Our objective is to raise awareness among physicians in general and psychiatrists and addiction specialists in particular of the potentially dangerous phenomenon of unsupervised nootropic use among young adults who may be especially vulnerable to nootropics' negative effects.
Keywords: Nootropics; cognitive enhancers; psychiatric adverse effects; substance abuse; substance misuse; supplements.
Similar articles
-
Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367. Nutrients. 2022. PMID: 36014874 Free PMC article. Review.
-
Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.Evid Based Complement Alternat Med. 2016;2016:4391375. doi: 10.1155/2016/4391375. Epub 2016 Aug 30. Evid Based Complement Alternat Med. 2016. PMID: 27656235 Free PMC article. Review.
-
[Acting out and psychoactive substances: alcohol, drugs, illicit substances].Encephale. 2001 Jul-Aug;27(4):351-9. Encephale. 2001. PMID: 11686057 Review. French.
-
Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review.J Exp Pharmacol. 2012 Dec 11;4:163-72. doi: 10.2147/JEP.S35326. eCollection 2012. J Exp Pharmacol. 2012. PMID: 27186129 Free PMC article. Review.
-
Training the next generation of providers in addiction medicine.Psychiatr Clin North Am. 2012 Jun;35(2):461-80. doi: 10.1016/j.psc.2012.04.001. Psychiatr Clin North Am. 2012. PMID: 22640766
Cited by
-
Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells.Sci Rep. 2021 Oct 29;11(1):21335. doi: 10.1038/s41598-021-00836-z. Sci Rep. 2021. PMID: 34716387 Free PMC article.
-
Neuronutraceuticals Combating Neuroinflammaging: Molecular Insights and Translational Challenges-A Systematic Review.Nutrients. 2022 Jul 23;14(15):3029. doi: 10.3390/nu14153029. Nutrients. 2022. PMID: 35893883 Free PMC article.
-
Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives.Saudi Pharm J. 2021 Aug;29(8):879-907. doi: 10.1016/j.jsps.2021.07.003. Epub 2021 Jul 15. Saudi Pharm J. 2021. PMID: 34408548 Free PMC article. Review.
-
Vigilance Decrement and Enhancement Techniques: A Review.Brain Sci. 2019 Jul 26;9(8):178. doi: 10.3390/brainsci9080178. Brain Sci. 2019. PMID: 31357524 Free PMC article. Review.
-
Extract of Xylopia aethiopica and its kaurene diterpene, xylopic acid, improve learning and memory in mice.IBRO Neurosci Rep. 2022 Mar 29;12:249-259. doi: 10.1016/j.ibneur.2022.03.006. eCollection 2022 Jun. IBRO Neurosci Rep. 2022. PMID: 35746979 Free PMC article.
References
-
- Nishizaki T, Matsuoka T, Nomura T, et al. A long-term, potentiation-like facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Brain Res. 1999;826:281–288. - PubMed
-
- Turner DC, Robbins TW, Clark L, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology. 2003;165(3):260–269. - PubMed
-
- Turner DC, Clark L, Dowson J, et al. Modafinil improves cognition and response inhibition in adult attention- deficit/hyperactivity disorder. Biol Psychiatry. 2004;55:1031–1040. - PubMed
-
- Ferraro L, AntonelliT, Tanganelli S, et al. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology. 1999;20:346–356. - PubMed
-
- Darwish M, Kirby M, Hellriegel ET. Robertson P Jr. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives. Clin Drug Investig. 2009;29(9):613–623. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources